BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10183698)

  • 1. Nonionic contrast media open new paths for MRI.
    D'Agincourt L
    Diagn Imaging (San Franc); 1990 May; 12(5):90-6. PubMed ID: 10183698
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the safety and efficacy of gadoteridol injection (a low osmolal magnetic resonance contrast agent). Clinical trials report.
    DeSimone D; Morris M; Rhoda C; Lucas T; Zielonka J; Olukotun A; Carvlin M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S212-6; discussion S232-5. PubMed ID: 1808133
    [No Abstract]   [Full Text] [Related]  

  • 3. Technical considerations of spinal imaging at 1.5 T.
    Berns DH
    Top Magn Reson Imaging; 1988 Dec; 1(1):1-10. PubMed ID: 3078533
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous nodules, pain, and thrombophlebitis as an adverse reaction to gadolinium contrast media.
    Murphy KJ; Hansen R; Prince MR
    AJR Am J Roentgenol; 1997 Jul; 169(1):318-9. PubMed ID: 9207574
    [No Abstract]   [Full Text] [Related]  

  • 5. Considerations in the choice of contrast media for MR imaging.
    Brasch RC; Bennett HF
    Radiology; 1988 Mar; 166(3):897-9. PubMed ID: 3340795
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA. Results of a randomized, controlled clinical trial.
    Niendorf HP; Haustein J; Louton T; Beck W; Laniado M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S221-3; discussion S232-5. PubMed ID: 1808134
    [No Abstract]   [Full Text] [Related]  

  • 7. Pediatric spinal neoplasms.
    Blaser S; Harwood-Nash D
    Top Magn Reson Imaging; 1993; 5(3):190-202. PubMed ID: 8347341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for the use of Gd-DTPA in MRI of the central nervous system. Experiences in patients with cerebral and spinal diseases.
    Bauer WM; Fenzl G; Vogl T; Fink U; Lissner J
    Invest Radiol; 1988 Sep; 23 Suppl 1():S286-8. PubMed ID: 3198363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute deterioration of myasthenia gravis after intravenous administration of gadolinium-DTPA.
    Nordenbo AM; Somnier FE
    Lancet; 1992 Nov; 340(8828):1168. PubMed ID: 1359250
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonionic magnetic resonance imaging contrast agents. Clinical trial experience of safety, tolerance, and efficacy of gadodiamide injection.
    Van Wagoner M; O'Toole M; Quay SC
    Invest Radiol; 1990 Sep; 25 Suppl 1():S39-41. PubMed ID: 2283251
    [No Abstract]   [Full Text] [Related]  

  • 11. Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA.
    Balériaux D; Matos C; De Greef D
    Neuroradiology; 1993; 35(7):490-4. PubMed ID: 8232870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Encephalopathy and Cardiac Arrest Induced by Intrathecal Gadolinium Administration.
    Besteher B; Chung HY; Mayer TE; Witte OW; Kirchhof K; Schwab M
    Clin Neuroradiol; 2020 Sep; 30(3):629-631. PubMed ID: 31679044
    [No Abstract]   [Full Text] [Related]  

  • 13. Pruritus and paresthesia after i.v. administration of Gd-DTPA.
    Chan K; Bosanko CM; Wang AM
    AJNR Am J Neuroradiol; 1989; 10(5 Suppl):S53. PubMed ID: 2505565
    [No Abstract]   [Full Text] [Related]  

  • 14. [Magnetic resonance in oncology].
    Terrier F; Schuknecht B; Fretz C; Vock P; Herschkowitz N
    Schweiz Med Wochenschr; 1990 Sep; 120(35):1257-72. PubMed ID: 2218448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI in monitoring the treatment of multiple sclerosis: concerted action guidelines.
    Paty DW; Li DK; Koopmans R
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):978. PubMed ID: 1431970
    [No Abstract]   [Full Text] [Related]  

  • 16. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
    Kallen AJ; Jhung MA; Cheng S; Hess T; Turabelidze G; Abramova L; Arduino M; Guarner J; Pollack B; Saab G; Patel PR
    Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spinal intra- and extramedullary capillary hemangioma--MRI of a rare entity].
    Miese F; Sabel M; Schellhammer F
    Rofo; 2008 Mar; 180(3):254-5. PubMed ID: 18278734
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential side effects of gadolinium-enhanced MRI .
    Smith SM; Hoag SD
    Am Fam Physician; 2009 Aug; 80(3):214. PubMed ID: 19642251
    [No Abstract]   [Full Text] [Related]  

  • 19. MR depicts perfusion of brain and heart.
    Rosen BR; Turner R; Hunter GJ; Fordham JA
    Diagn Imaging (San Franc); 1991 Nov; 13(11):105-10. PubMed ID: 10183706
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in magnetic resonance (2006).
    Runge VM
    Invest Radiol; 2006 Dec; 41(12):904-9. PubMed ID: 17099430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.